share_log

HC Wainwright & Co. Reiterates Buy on Bicycle Therapeutics, Maintains $55 Price Target

HC Wainwright & Co. Reiterates Buy on Bicycle Therapeutics, Maintains $55 Price Target

HC Wainwright & Co.重申買入自行車療法,維持55美元的目標股價
Benzinga ·  05/03 15:20

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Bicycle Therapeutics (NASDAQ:BCYC) with a Buy and maintains $55 price target.

HC Wainwright & Co. 分析師Swayampakula Ramakanth重申Bicycle Therapeutics(納斯達克股票代碼:BCYC)的買入並維持55美元的目標股價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論